Dishman Carbogen Amcis Ltd.
₹224.62+2.25%Dec 15, 3:45 PM IST
DCAL•Health Technology•Pharmaceuticals: Major
Current Price
₹224.62+2.25%
Dec 15, 3:45 PM ISTMarket Cap₹3,450.01 Cr
Market Cap₹3,450.01 Cr
Business Overview
Dishman Carbogen Amcis Limited operates through 2 main business divisions including CRAMS (Contract Research and Manufacturing Services), Marketable Molecules.
Business Hierarchy Structure for Dishman Carbogen Amcis Limited
- Dishman Carbogen Amcis Limited
- CRAMS (Contract Research and Manufacturing Services)
- Integrated CRAMS Offerings
- Research & Development Services
- Drug Discovery
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Market
- Process Development & Scale-up
- Process R&D
- API Supply (for clinical requirements)
- Process Development and Scale-up
- Process Optimization
- Commercial Manufacturing
- Niche Scale Commercial Manufacturing
- Large-Scale Commercial Manufacturing
- Specialized Capabilities
- High Potency API Supply
- Antibody Drug Conjugate (ADC) Manufacturing
- Warhead Linker Synthesis for ADCs
- Liquid & Lyophilized Sterile Injectable Formulation Capabilities
- Research & Development Services
- Integrated CRAMS Offerings
- Marketable Molecules
- Specialty Chemicals
- Intermediates
- Fine Chemicals
- Quaternary Compounds
- Phosphoranes
- Wittig Reagents
- Antiseptics
- Disinfectants
- Vitamins and Analogues
- Vitamin D Analogues
- Generic APIs
- Disinfectant Formulations
- Cholesterol Lanolin Related Products
- Sterile Injectables
- Specialty Chemicals
- CRAMS (Contract Research and Manufacturing Services)